Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies: Factors Impacting Its Occurrence and Treatment Options for a Better Management

被引:0
|
作者
Michallet, Mauricette [1 ]
Sobh, Mohamad [1 ]
Morisset, Stephane [1 ]
Labussiere, Helene [1 ]
Detrait, Marie Y. [1 ]
Ducastelle, Sophie [1 ]
Barraco, Fiorenza [1 ]
Fattoum, Jihane [1 ]
Tedone, Nathalie [1 ]
Chelghoum, Youcef [1 ]
Cannas, Giovanna [1 ]
Thomas, Xavier [1 ]
Nicolini, Franck E.
机构
[1] Univ Lyon 1, Hop Edouard Herriot, HCL, F-69365 Lyon, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1747 / 1748
页数:2
相关论文
共 50 条
  • [1] RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES: FACTORS IMPACTING ITS OCCURRENCE AND TREATMENT OPTIONS FOR A BETTER MANAGEMENT
    Michallet, M.
    Sobh, M.
    Morisset, S.
    Detrait, M.
    Labussiere, H.
    Ducastelle, S.
    Barraco, F.
    Chelghoum, Y.
    Thomas, X.
    Nicolini, F. E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S336 - S336
  • [2] RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES: FACTORS IMPACTING ITS OCCURRENCE AND TREATMENT OPTIONS FOR A BETTER MANAGEMENT
    Michallet, M.
    Sobh, M.
    Morisset, S.
    Detrait, M.
    Labussiere, H.
    Ducastelle, S.
    Barraco, F.
    Chelghoum, Y.
    Thomas, X.
    Nicolini, F.
    HAEMATOLOGICA, 2012, 97 : 402 - 403
  • [3] Relapse after allogeneic haematopoietic stem cell transplantation in haematological malignancies: factors impacting its occurrence and treatment options for a better management
    Michallet, M.
    Sobh, M.
    Morisset, S.
    Detrait, M.
    Barraco, F.
    Labussiere, H.
    Ducastelle, S.
    Tedone, N.
    Chelghoum, Y.
    Thomas, X.
    Nicolini, F.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S271 - S271
  • [4] Daratumumab and Venetoclax-Containing Regimens in the Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies
    Yang, Fan
    Li, Zhihui
    Dong, Changwei
    Lei, Yang
    Geng, YanPing
    Wen, XiaoPei
    Zhou, Yan
    Wu, Tong
    BLOOD, 2020, 136
  • [5] Stem-cell dose for allogeneic hematopoietic stem cell transplantation in hematological malignancies: is more better?
    Shimoni, Avichai
    Nagler, Arnon
    LEUKEMIA & LYMPHOMA, 2009, 50 (09) : 1395 - 1396
  • [6] Allogeneic hematopoietic stem-cell transplantation for hematological malignancies
    Michallet, M
    Dhedin, N
    Michallet, AS
    BULLETIN DU CANCER, 2001, 88 (09) : 908 - 926
  • [7] Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review
    Frédéric Baron
    Rainer Storb
    Springer Seminars in Immunopathology, 2004, 26 : 71 - 94
  • [8] Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review
    Baron, F
    Storb, R
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2004, 26 (1-2): : 71 - 94
  • [9] Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation
    Godfrey, James
    Liu, Hongtao
    Yu, Jovian
    Tallarico, Michael
    Curran, Emily
    Artz, Andrew
    Riedell, Peter A.
    Stock, Wendy
    Karrison, Theodore
    Fitzpatrick, Carrie
    Venkataraman, Girish
    Cooper, Alan
    Smith, Sonali M.
    Bishop, Michael R.
    Kline, Justin
    BLOOD ADVANCES, 2023, 7 (06) : 963 - 970
  • [10] IMPACT OF CHRONIC GVHD ON LATE RELAPSE, TREATMENT RELATED MORTALITY AND SURVIVAL AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES
    Boyiadzis, M.
    Klein, J. P.
    Arora, M.
    Weisdorf, D. J.
    Hassebroek, A.
    Lee, S. J.
    Flowers, M. E.
    Cutler, C. S.
    Urbano-Ispizua, A.
    Antin, J. H.
    Bolwell, B. J.
    Cahn, J-Y
    Cairo, M. S.
    Gale, R. P.
    Herzig, R. H.
    Isola, L. M.
    Jacobsohn, D. A.
    Jagasia, M. H.
    Klumpp, T. R.
    Petersdorf, E. W.
    Wingard, J. R.
    Horowitz, M. M.
    Pavletic, S. Z.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S209 - S210